2021
How the scientific community responded to the COVID-19 pandemic: A subject-level time-trend bibliometric analysis
Malekpour M, Abbasi-Kangevari M, Azadnajafabad S, Ghamari S, Rezaei N, Rezazadeh-Khadem S, Rezaei N, Aminorroaya A, Abdolhamidi E, Fateh S, Haghshenas R, Roshani S, Ahmadi N, Jamshidi K, Naderimagham S, Farzadfar F. How the scientific community responded to the COVID-19 pandemic: A subject-level time-trend bibliometric analysis. PLOS ONE 2021, 16: e0258064. PMID: 34591941, PMCID: PMC8483337, DOI: 10.1371/journal.pone.0258064.Peer-Reviewed Original ResearchConceptsPublication countsBibliographic recordsBibliometric analysisScience domainBibliographic dataCOVID-19 literatureInternational collaborationResearch publicationsVital fundsMedical publicationsPhysical sciencesOngoing situationAnalysis backgroundSocial sciencesScientific community's interestCollaborationLife sciencesScienceRedundancyDomainMedical subjectsClassificationScientific communityInternational publicationsCommunity interestsHow Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19?
Shafeghat M, Aminorroaya A, Rezaei N. How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19? Acta BioMedica 2021, 92: e2021512. PMID: 34738559, PMCID: PMC8689303, DOI: 10.23750/abm.v92i5.12013.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeCoronary artery diseaseStable coronary artery diseaseCoronary syndromeProgression to acute coronary syndromesCytotoxic T-cell lymphocytesIncidence of myocardial injuryOut-of-hospital cardiac arrestStable ischemic heart diseaseProgression of stable coronary artery diseaseIncreased mortality risk of patientsRate of out-of-hospital cardiac arrestMalignant ventricular arrhythmiasT-cell lymphocytesMortality risk of patientsRisk of patientsIschemic heart diseaseWorld Health Organization protocolCOVID-19 patientsIncreased mortality riskVentricular arrhythmiasSystemic inflammationCardiac arrestCytokine releaseFollow-up
2020
Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Soleimani A, Kazemian S, Saleh S, Aminorroaya A, Shajari Z, Hadadi A, Talebpour M, Sadeghian H, Payandemehr P, Sotoodehnia M, Bahreini M, Najmeddin F, Heidarzadeh A, Zivari E, Ashraf H. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. American Journal Of Hypertension 2020, 33: 1102-1111. PMID: 32920644, PMCID: PMC7543264, DOI: 10.1093/ajh/hpaa149.Peer-Reviewed Original ResearchConceptsAngiotensin II receptor blockersAngiotensin-converting enzyme inhibitorsIn-hospital outcomesAcute kidney injuryClinically suspected COVID-19Severe COVID-19Receptor blockersEffects of angiotensin receptor blockersWorld Health Organization interim guidanceBenefits of angiotensin-converting enzyme inhibitorsIn-hospital outcomes of patientsAssociated with poor in-hospital outcomesFollowed-up patientsPoor in-hospital outcomesOutcomes of patientsAngiotensin receptor blockersII receptor blockersRetrospective observational studyIn-hospital complicationsIncomplete medical recordsRisk of mortalityClinical suspicionInvasive ventilationHypertensive patientsKidney injury